Eikon Therapeutics

Ex-Merck R&D chief Perlmutter takes reins at drug discovery startup Eikon

A new drug discovery firm, Eikon Therapeutics, has launched with former Merck & Co research chief Roger Perlmutter at the helm. Eikon is backed with $148 million in Series A financing led by The Column Group, with Foresite Capital, Innovation Endeavors and Lux Capital also joining. The California-based company said it aims to use super-resolution …

Ex-Merck R&D chief Perlmutter takes reins at drug discovery startup Eikon Read More »

Ex-Merck R&D chief Perlmutter takes reins at drug discovery startup Eikon

A new drug discovery firm, Eikon Therapeutics, has launched with former Merck & Co research chief Roger Perlmutter at the helm. Eikon is backed with $148 million in Series A financing led by The Column Group, with Foresite Capital, Innovation Endeavors and Lux Capital also joining. The California-based company said it aims to use super-resolution …

Ex-Merck R&D chief Perlmutter takes reins at drug discovery startup Eikon Read More »